标准研究

国家药品标准物质标签及其说明书管理的风险控制

展开
  • 中国食品药品检定研究院, 北京 102629

网络出版日期: 2019-04-24

Risk Control of Management for Standard Labels and Instructions of National Pharmaceutical Reference Standards

Expand
  • National Institutes for Food and Drug Control, Beijing 102629, China

Online published: 2019-04-24

摘要

目的:减少国家药品标准物质标签及其说明书管理风险的发生及降低风险引发的损失。方法:根据目前国家药品标准物质标签及其说明书管理现状及存在问题,制定一系列措施和方法进行风险控制。结果:规范国家药品标准物质标签及其说明书的录入、审核和排版环节,完善相关质量管理控制体系;建立风险评估和控制机制,提高风险意识、风险知识和工作责任心。结论:通过建立国家药品标准物质标签及其说明书管理的风险评估和控制机制,堵住和减少风险漏洞,降低风险引发的损失,保证国家药品标准物质的质量与安全,为用户提供准确无误的信息。

本文引用格式

王雅君, 王丽, 赵宗阁 . 国家药品标准物质标签及其说明书管理的风险控制[J]. 中国药事, 2019 , 33(4) : 399 -401 . DOI: 10.16153/j.1002-7777.2019.04.008

Abstract

Objective: To reduce the management risk of the labels and instructions of national pharmaceutical reference standards and reduce the losses caused by the risk. Methods: Causes of the risk were analyzed according to current management situation and existing problems of labels and instructions of the national pharmaceutical reference standards. A series of measures and methods were developed to control the risk. Results: The preparation and production of the labels and instructions of national pharmaceutical reference standards were standardized. A standarized quality control system and risk assessment control system were established. Risk awareness and knowledge of the staff were improved and responsibilities of the staff were enhanced. Moreover, risk management system was updated in a real time manner. Conclusions: Management of labels and instructions of national pharmaceutical reference standards is strengthened through establishing the risk control of the management of labels and instructions of national pharmaceutical reference standards, management risk and the losses caused by the risk are reduced. In this way, quality and safety of national pharmaceutical reference standards is guaranteed and accurate information can be provided for users.

参考文献

[1] 汪开敏,柴玉生,陈国庆,等. 药品标准物质的量值溯源与量值传递工作原则[J]. 中国药事,1998,12(2):113-116.
[2] 中华人民共和国主席令第45号药品管理法[S]. 2001.
[3] 吴红雁,冯国忠. 新药研发过程中的风险管理[J]. 上海医药,2007,28(12):541-542.
[4] 李幼平,文进,王莉. 药品风险管理:概念、原则、研究方法与实践[J]. 中国循证医学杂志,2007,7(12):843-848.
[5] 孔令丽. 质量风险管理在药品生产过程中的应用[J]. 北方药学,2015,12(2):146-147.
Options
文章导航

/